Publication:
Synthesis of some new triazene and diazene derivatives and in vitro evaluation of preliminary antitumor activities

dc.contributor.authorsÇikla P., Rollas S.
dc.date.accessioned2022-03-28T14:54:25Z
dc.date.accessioned2026-01-11T15:23:26Z
dc.date.available2022-03-28T14:54:25Z
dc.date.issued2007
dc.description.abstractIn this study, a number of novel triazene and diazene derivatives (1a-g) were designed and synthesized by utilizing the coupling of diazonium salts of 5-(4-aminophenyl)-2,4-dihydro-4-allyl-3H-1,2,4-triazole-3-thione, 4-aminobenzoic acid, sulfanilamide, sulfathiazole, benzocaine, sulfaguanidine and sulfadiazine containing an aromatic primary amine group with N-methylaniline. The structures of the synthesized compounds were confirmed by the spectral data (UV, IR, 1H-NMR) and elemental analysis. Testing of preliminary antitumor activity of these compounds in vitro against Huh-7 liver cancer cell demonstrated 4-allyl-5-[4-(3-methyl-3-phenyltriaz-1-enyl)phenyl]-2,4-dihydro-3H- 1,2,4-triazole-3-thione compound 1a and 4-(3-methyl-3-phenyltriaz-1-enyl) benzenesulfonamide compound 1c to have inhibitory activity.
dc.identifier.issn13004182
dc.identifier.urihttps://hdl.handle.net/11424/256133
dc.language.isoeng
dc.relation.ispartofFabad Journal of Pharmaceutical Sciences
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectDiazene
dc.subjectSynthesis
dc.subjectTriazene
dc.titleSynthesis of some new triazene and diazene derivatives and in vitro evaluation of preliminary antitumor activities
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage40
oaire.citation.issue1
oaire.citation.startPage33
oaire.citation.titleFabad Journal of Pharmaceutical Sciences
oaire.citation.volume32

Files